Notice Number: NOT-AG-18-058
Key Dates
Release Date: January 4, 2019
RFA-AG-19-025
Issued by
National Institute on Aging (NIA)
Purpose
The purpose of this Notice is to amend the application types allowed, award budget, and award project period for RFA-AG-19-025 "Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R43/R44 Clinical Trial Not Allowed)".
Part 2, Section II, Award Information
Application Types Allowed
Currently reads:
New (Phase I, Fast-Track)
New (Phase II)
The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.
Modified to read:New (Phase I, Fast-Track)
New (Phase II)
New (Direct Phase II)
The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.
Award Budget
Currently reads:
Budgets up to $225,000 total costs per year for Phase I and up to $750,000 total costs per year for Phase II may be requested with appropriate justification.
Modified to read:
Budgets up to $300,000 total costs for Phase I and up to $1,000,000 total costs per year for Phase II may be requested with appropriate justification.
Award Project Period
Currently reads:
According to statutory guidelines, award periods normally may not exceed 6 months for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research project.
Modified to read:
According to statutory guidelines, award periods normally may not exceed 1 year for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research project.
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Todd Haim, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-480-7867
Email: todd.haim@nih.gov
and Human Services (HHS)
